ACT-AEC Consortium Funding for CanStroke Trial Investigators
Dr. Janice Eng and other CanStroke investigators were successful in the most recent Accelerating Clinical Trials (ACT) funding competition supporting knowledge mobilization of high impact randomized controlled trials in Canada. This funding will go towards the dissemination of study results and creating resources to support the implementation of the Walk ‘N Watch protocol.
The Accelerating Clinical Trials Consortium is supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.